GlassScriptPhysician profile
Cheyne Roberts
NPI 1053099168
$2,143.19
in general payments reported to CMS, 2019-2025
15 companies · $783 in 2025
The $783 reported for 2025 was more than what 83% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $99.02 · 2024: $1,261 · 2025: $783.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,143.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $555.67 | 2023-2025 | Airsupra, Farxiga, Breztri |
| Amgen INC. | $299.97 | 2024-2025 | Evenity, Prolia, Otezla |
| Novo Nordisk INC | $284.37 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Glaxosmithkline, LLC. | $204.21 | 2023-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $171.74 | 2023-2024 | Mounjaro, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $121.77 | 2024-2025 | |
| Astellas Pharma US INC | $89.92 | 2024-2025 | Veozah |
| Boehringer Ingelheim Pharmaceuticals, INC. | $88.76 | 2024-2025 | Jardiance |
| Phathom Pharmaceuticals, INC. | $85.62 | 2024-2025 | Voquezna |
| Exact Sciences Corporation | $73.29 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Dexcom, INC. | $43.63 | 2024-2025 | Dexcom G6 Transmitter |
| Pfizer INC. | $42.91 | 2024-2025 | |
| Abbvie INC. | $39.86 | 2024-2025 | |
| Lundbeck LLC | $24.16 | 2025 | Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $17.31 | 2024 | Caplyta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheyne Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.